L.F.A.G. Massuger

639 total citations
32 papers, 474 citations indexed

About

L.F.A.G. Massuger is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L.F.A.G. Massuger has authored 32 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L.F.A.G. Massuger's work include Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). L.F.A.G. Massuger is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). L.F.A.G. Massuger collaborates with scholars based in Netherlands, United States and United Kingdom. L.F.A.G. Massuger's co-authors include Jelle O. Barentsz, Ruud L.M. Bekkers, C.P.T. Schijf, Toon Van Gorp, Johan Bulten, Steven W.M. Olde Damink, Jorne Ubachs, Iris J.G. Rutten, David P.J. van Dijk and Regina G. H. Beets‐Tan and has published in prestigious journals such as Clinical Chemistry, Human Reproduction and European Journal of Cancer.

In The Last Decade

L.F.A.G. Massuger

32 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L.F.A.G. Massuger Netherlands	11	183	143	128	113	86	32	474
Kelly J. Manahan United States	14	166 0.9×	241 1.7×	12 0.1×	187 1.7×	111 1.3×	46	563
José Manuel Aramendía Spain	14	76 0.4×	60 0.4×	46 0.4×	104 0.9×	326 3.8×	46	587
David P. Schammel United States	14	324 1.8×	226 1.6×	10 0.1×	70 0.6×	122 1.4×	34	643
Scott P. Tannehill United States	8	74 0.4×	132 0.9×	95 0.7×	163 1.4×	122 1.4×	15	464
F Mazzeo Belgium	8	75 0.4×	40 0.3×	30 0.2×	215 1.9×	220 2.6×	29	462
Xue Yu China	11	57 0.3×	87 0.6×	88 0.7×	55 0.5×	21 0.2×	42	412
Bradford P. Whitcomb United States	12	385 2.1×	314 2.2×	77 0.6×	165 1.5×	63 0.7×	18	686
Daniel S. Metzinger United States	14	591 3.2×	643 4.5×	18 0.1×	344 3.0×	93 1.1×	33	1.1k
Hidenobu Matsushita Japan	12	29 0.2×	21 0.1×	23 0.2×	232 2.1×	158 1.8×	51	500
José Luis Alonso-Romero Spain	14	69 0.4×	42 0.3×	14 0.1×	135 1.2×	227 2.6×	47	517

Countries citing papers authored by L.F.A.G. Massuger

Since Specialization

Citations

This map shows the geographic impact of L.F.A.G. Massuger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.F.A.G. Massuger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.F.A.G. Massuger more than expected).

Fields of papers citing papers by L.F.A.G. Massuger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.F.A.G. Massuger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.F.A.G. Massuger. The network helps show where L.F.A.G. Massuger may publish in the future.

Co-authorship network of co-authors of L.F.A.G. Massuger

This figure shows the co-authorship network connecting the top 25 collaborators of L.F.A.G. Massuger. A scholar is included among the top collaborators of L.F.A.G. Massuger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.F.A.G. Massuger. L.F.A.G. Massuger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Massuger, L.F.A.G., et al.. (2019). EP1180 Incidence and prognostic factors for inguinofemoral lymph node metastasis in patients with a first local recurrence of vulvar squamous cell carcinoma. A609.2–A609. 2 indexed citations

Massuger, L.F.A.G., et al.. (2019). EP645 Anti-estrogen treatment in endometrial cancer: a systematic review. A374.1–A374. 3 indexed citations

Smits, Anke, John McGrane, Alberto Lopes, et al.. (2017). Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?. International Journal of Clinical Oncology. 22(5). 945–953. 7 indexed citations

Rutten, Iris J.G., Jorne Ubachs, Roy F.P.M. Kruitwagen, et al.. (2017). The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery. European Journal of Surgical Oncology. 43(4). 717–724. 84 indexed citations

Siebers, Albert G., et al.. (2016). The value of fine needle aspiration cytology diagnosis in ovarian masses in children and adolescents. Human Reproduction. 31(6). 1236–1240. 6 indexed citations

Smits, Anke, Alberto Lopes, N Das, et al.. (2015). Surgical morbidity and clinical outcomes in ovarian cancer – the role of obesity. BJOG An International Journal of Obstetrics & Gynaecology. 123(2). 300–308. 53 indexed citations

Tilborg, Angela A.G. van, Fred C.G.J. Sweep, Anneke Geurts‐Moespot, et al.. (2014). Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids. International Journal of Oncology. 44(4). 1394–1400. 10 indexed citations

Dijck, J.A.A.M. van, et al.. (2009). Vagina- en cervixcarcinoom door diëthylstilbestrol (des). Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 153. 1 indexed citations

Siebers, Albert G., André L. M. Verbeek, L.F.A.G. Massuger, Johanna M. M. Grefte, & Johan Bulten. (2006). Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology. International Journal of Gynecological Cancer. 16(3). 1069–1074. 14 indexed citations

10.

Hamont, Dennis van, et al.. (2006). Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia. International Journal of Gynecological Cancer. 16(2). 615–619. 4 indexed citations

11.

Bulten, Johan, et al.. (2004). Malignant peritoneal mesothelioma in a 76-year-old woman with a history of asbestos fiber ingestion. International Journal of Gynecological Cancer. 14(1). 162–165. 3 indexed citations

12.

Bekkers, Ruud L.M., Johan Bulten, Antonius G.J.M. Hanselaar, et al.. (2002). The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix. International Journal of Gynecological Cancer. 12(5). 485–489. 20 indexed citations

13.

Bekkers, Ruud L.M., et al.. (2002). The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix. International Journal of Gynecological Cancer. 12(5). 485–489. 8 indexed citations

14.

Massuger, L.F.A.G., et al.. (1998). Fast dynamic contrast enhanced MR imaging of cervical carcinoma. Clinical Radiology. 53(3). 183–192. 39 indexed citations

15.

Massuger, L.F.A.G., et al.. (1998). Borderline ovarian malignancy: ultrasound and fast dynamic MR findings. European Journal of Radiology. 28(2). 136–142. 39 indexed citations

16.

Buijs, W C, Otto C. Boerman, Carla F.M. Molthoff, et al.. (1998). Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration. European Journal of Nuclear Medicine and Molecular Imaging. 25(11). 1552–1561. 40 indexed citations

17.

Koper, N.P., Chris M.G. Thomas, L.F.A.G. Massuger, et al.. (1997). Serum CA 125 concentrations in women of different ages, hormonal statuses, orclinical conditions. International Journal of Gynecological Cancer. 7(5). 405–411. 4 indexed citations

18.

Massuger, L.F.A.G., et al.. (1995). Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients. Nuclear Medicine Communications. 16(10). 853–859. 6 indexed citations

19.

Thomas, Chris M.G., L.F.A.G. Massuger, M F Segers, et al.. (1995). Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA. Clinical Chemistry. 41(2). 211–216. 10 indexed citations

20.

Kenemans, Peter, Chris M.G. Thomas, L.F.A.G. Massuger, et al.. (1993). CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery. European Journal of Cancer. 29(7). 966–971. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact